THERAPTOSIS S A has a total of 21 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SMYTH MARK S, SANDOZ PHARMA UK and ENDOCUBE SAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | China | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Jacotot Etienne | 11 |
#2 | Rebouillat Dominique | 10 |
#3 | Lecoeur Herve | 6 |
#4 | Chauvier David | 6 |
#5 | Casimir Richard | 5 |
#6 | Baux Ludwig | 3 |
#7 | Rustin Pierre | 3 |
#8 | Hoebeke Johan | 3 |
#9 | Richard Casimir | 2 |
#10 | David Chauvier | 2 |
Publication | Filing date | Title |
---|---|---|
WO2008004130A2 | Peptides for targeting the mitochondrial transition pore complex for therapeutic apoptosis induction and biological applications | |
CN103059100A | New peptides useful as dual caspase-2/-6 inhibitor and biological application thereof | |
US2007275432A1 | Means for a Quantitative Detection of Cytochrome C | |
CN1720452A | Method for screening modulators of mitochondrial fuctionning and new modulators obtained | |
EP1925625A2 | Method for screening modulators of mitochondrial functionning and new modulators obtained | |
WO2004031768A2 | Method for screening modulators of mitochondrial functioning |